メインコンテンツに移動
  • ELGAについて
    • ELGAについて
    • 超純水
    • 純水製造技術
    • 水中の不純物
    • ガイド&ホワイトペーパー
    • 認定パートナー
    • サステナビリティ
    • 臨床でのリスクの低減
    • 採用情報
    • イベント
    • 製薬におけるHPLC
    • HPLC用水の純度
  • ブログ
    • Analytical Chemistry
    • Clinical & Pharma
    • Cool Science
    • Environment and sustainability
    • Life in the lab
    • Purelab product design
    • Science of the future
    • Water Purity
    • Water in the lab
  • お問い合わせ
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 中文
ホーム ELGA LabWater
  • 製品
  • 用途
  • ケーススタディ
  • サポート
  • 製品
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • ELGA全製品ライン
  • 用途
  • ケーススタディ
    • 南アジアのAbbott Diagnostics、ELGA MEDICAシステムを選択
    • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
    • Clean Water for a Clean Future
    • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
    • DASA:ブラジル最大の医療診断企業
    • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
    • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
    • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
    • PURELAB® flex:現代的な研究手法における理想的なトレーニングシステム
    • Powering Cutting-Edge Gene Research
    • Sichere Reinstwasserversorgung für präzise Produkttests
    • Siemens ADVIA分析装置用に市立総合病院がMEDICA®Proを導入
    • Zentrale Reinstwasser-Aufbereitung für Analyser
    • ジェネリック医薬品開発における超純水(I型水+)の重要性
    • 免疫血清学ラボの稼働時間最大化を支援するELGA
    • ELGA LabWater and Beckman Coulter Join Forces
    • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
    • 超純水により南極の謎を解明
    • Advancing Genetic Technologies
    • Cross Infection Control: Pure and Simple
    • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
  • サポート
    • サポート&サービス
    • ラボのプランニング
    • 製品を登録
    • Register Your Product (USA & Canada Only)
  • 製品
    • PURELAB
      • PURELAB® flex 1 & 2
      • PURELAB® flex 3 & 4
    • CENTRA
      • CENTRA® 60/120
      • CENTRA® RDS
      • CENTRA® R200
    • MEDICA
      • MEDICA® 7/15
      • MEDICA® EDI 15/30
      • MEDICA® Pro EDI 60/120
      • MEDICA® Pro-LPS
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
    • BIOPURE
      • BIOPURE 7/15
      • BIOPURE 60/120
      • BIOPURE 200/300/600
    • ELGA全製品ライン
      • PURELAB® Classic
  • 用途
  • ケーススタディ
    • 南アジアのAbbott Diagnostics、ELGA MEDICAシステムを選択
    • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
    • Clean Water for a Clean Future
    • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
    • DASA:ブラジル最大の医療診断企業
    • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
    • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
    • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
    • PURELAB® flex:現代的な研究手法における理想的なトレーニングシステム
    • Powering Cutting-Edge Gene Research
    • Sichere Reinstwasserversorgung für präzise Produkttests
    • Siemens ADVIA分析装置用に市立総合病院がMEDICA®Proを導入
    • Zentrale Reinstwasser-Aufbereitung für Analyser
    • ジェネリック医薬品開発における超純水(I型水+)の重要性
    • 免疫血清学ラボの稼働時間最大化を支援するELGA
    • ELGA LabWater and Beckman Coulter Join Forces
    • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
    • 超純水により南極の謎を解明
    • Advancing Genetic Technologies
    • Cross Infection Control: Pure and Simple
    • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
  • サポート
    • サポート&サービス
    • ラボのプランニング
    • 製品を登録
    • Register Your Product (USA & Canada Only)
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 中文
  • プライバシーポリシー
  • 利用規約
  • 世界的な法令順守
  • 特許
  • サイト管理者情報
  • ホーム
  • Node
  • Exploring The Origins Of Childhood Leukaemia
Analytical Chemistry
Science of the Future

Exploring The Origins Of Childhood Leukaemia

29 3月 2020
- by Dr Alison Halliday

Child with Cancer

Researchers analyse archived newborn blood spots to look for exposures in the womb that may affect the risk of developing the most common childhood cancer.


Recent evidence suggests that childhood leukaemia involves at least two events – the first occurring when the baby is developing in the womb, with a second following after their birth. Although the precise factors that contribute to these events are not fully understood, the rising incidence of childhood leukaemia over time, particularly in affluent countries, suggests that environmental and lifestyle factors are involved.

Both the developing fetus and child are exposed to a multitude of potentially harmful chemicals – such as those generated from intrinsic metabolic processes or from exogenous sources including infections, diet or parental smoking.

Although many of these chemicals are stable molecules that can be measured with techniques such as metabolomics or proteomics, others are metabolised into electrophilic compounds that can alter physiological processes in early life but can’t be measured in the body. This makes it challenging for researchers to investigate their potential impact on the risk of developing a disease later in life.

A Proxy Marker In Newborn Blood Spots

The Cys34 residue of the most abundant blood protein, human serum albumin (HSA), is a powerful scavenger of electrophilic compounds. As its turnover in the body is 28 days, measuring the modifications (adducts) of this amino acid in archived newborn blood spots offers an indirect way to capture fetal exposures during the last month of pregnancy. 

In a new study, published in Leukemia Research, a team of researchers analysed these Cys34 adducts in the HSA protein in archived newborn blood spots as a way obtain new information about exposures in the womb and investigate how these may impact on the risk of childhood leukaemia.1 

The team used an adapted untargeted adductomics method based on nanoflow liquid chromatography-high resolution mass spectrometry (nLC-HRMS) to characterise Cys34 adducts in the archived newborn blood spots. They used ultrapure water from an ELGA PURELAB® laboratory water purification system to minimise the risk of introducing contaminants that may affect the results of this sensitive analytical technique.

Comparing Abundances In Cases And Controls

The researchers analysed 782 archived newborn blood spots collected from participants of the California Childhood Leukaemia Study (CCLS) – including 338 children with acute lymphoblastic leukaemia (ALL), 45 with acute myeloid leukaemia (AML) and matched healthy controls.

While they identified no clear associations between adduct abundance with either childhood leukaemia or ALL overall, they did identify differences between samples from children with subtypes of the disease and healthy controls – albeit in small sample sizes.

Children with T-cell ALL had higher abundances of adducts of reactive carbonyl species. And interestingly, there was a 44% decrease in abundances of a homocysteine adduct in AML cases.

Preventing Childhood Leukaemia

Although the results shed light on potential exposures involved in the development of certain subtypes of ALL before birth, larger studies are now needed to confirm these findings and further explore their implications.

As there are very few known lifestyle-related or environmental causes of childhood leukaemias, identifying modifiable risk factors could lead to new ways to help reduce the risk of the disease.

Why Choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. Our dedication to ultrapure and pure water is a guarantee that we will continue to provide the best solutions with the best service.


Reference:

  1. Yano, Y. et al. Untargeted Adductomics of Newborn Dried Blood Spots Identifies Modifications to Human Serum Albumin Associated with Childhood Leukaemia. Leukemia Research 2019; S0145-2126(19)30713-1.


Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

Quest Download

PURELAB Quest

The only purifier on the market that dispenses all 3 types of science ready water from a compact, economical and easy to use system!

             Click Here To Find Out More

 

  • Enquiry
  • 見積もりを取得
  • デモを予約する
  • 承認されたパートナーを見つける

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

見積もりを取得

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

デモを予約する

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater本社

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
電話: +44 (0) 203 567 7300
ファックス:+44 (0) 203 567 7205

超純水スペシャリスト

  • サポート&サービス
  • イベント

ケーススタディ

  • Abbott Diagnostics(アボットダイアグノスティクス)
  • DASA Medical Diagnostics(DASA医療診断)
  • NeoDIN Medical Institute(NeoDIN医療機関)
  • UHNS(University Hospital of North Staffordshire NHS Trust/北スタンフォードシャア大学病院)
  • Olsberg Vocational College(オルスバーグ専門学校)

リソース

  • 超純水について
  • ガイド&ホワイトペーパー
  • 純水製造技術
  • 用途
  • 水中の不純物

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • 言語
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • 他のVeoliaサイト
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

©VWS(UK)Ltd.はELGA LabWaterとして取引されています。2021-全著作権所有。
ELGAはVeoliaのグローバルなラボ用水のブランド名です。

  • プライバシーポリシー
  • 利用規約
  • 世界的な法令順守
  • 特許
  • サイト管理者情報
Elga Veolia
TOP

© 2017 ELGA Veolia